Erik Ullerås
Projektkoordinator vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Molekylära verktyg och funktionsgenomik; Forskargrupp Ulf Landegren
- Mobiltelefon:
- 070-167 95 63
- E-post:
- erik.ulleras@igp.uu.se
- Besöksadress:
- BMC, Husargatan 3
751 22 Uppsala - Postadress:
- Box 815
751 08 Uppsala
Forskningsrådgivare vid Universitetsförvaltningen; Områdeskanslier; Kansliet för medicin och farmaci; Enheten för forskningsstöd
- Telefon:
- 018-471 62 59
- Mobiltelefon:
- 070-167 95 63
- E-post:
- erik.ulleras@uadm.uu.se
- Besöksadress:
- Segerstedthuset, Dag Hammarskjölds väg 7
752 37 Uppsala - Postadress:
- Box 256
751 05 UPPSALA
- Akademiska meriter:
- FD, docent
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Projektkoordinator vid Kansliet för Medicin och Farmaci. Stöder forskare i frågor om EU-finansiering, från ansökan till avslutat projekt. Arbetar även med svenska forskningsfinansiärer och forskningsinfrastruktur. Projektkoordinator vid IGP för forskningsprogrammet molekylära verktyg. Arbetar med projektledning, ansökningar, förhandling och rapportering av ett stort antal nationella och internationella samarbetsprojekt som stöds av EU H2020, IMI, ERC, Eurostars, NIH, VR, SSF, KAW och Vinnova.
Nyckelord
- calls
- erc
- eu anslag
- eu call
- eu finansiering
- eu medel
- eu projekt
- eu support
- eu utlysning
- forskningsbidrag
- forskningsfinansiering
- forskningsinfrastruktur
- forskningsmedel
- forskningsstöd
- grants
- grants office
- horizon2020
- research infrastructure
- research support
- söka pengar
- utlysningar
Biografi
Denna text finns inte på svenska, därför visas den engelska versionen.
Background: MSc in Molecular Biology, PhD in Animal Development and Genetics, Associate Professor in Molecular Toxicology. Research experience from Science Faculty and Medical Faculty at Uppsala University, Karolinska Institute and Faculty of Veterinary Medicine at Swedish University of Agricultural Sciences.
Research profile: Focus on effects on gene expression and cellular activities in disease and follwing toxic exposure. Experience including studies on transcriptional regulation in tumours, tumour hypoxia, cytokine expression as marker for immuotoxicity, regulation of mast cell apoptosis and survival, gene expression as marker of developmental toxicity and effects of endocrine disruptors on adrenal steroidogenesis.
Current position: includes project management and administration, strategic advice and intelligence, coordination, recruiment of staff, budgeting, negotiation of agreements, information via web and outreach, interaction with industry and other stakeholders plus organization of meetings.
Publikationer
Senaste publikationer
- Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens (2016)
- Öppenheten förstör chansen till patent (2015)
- Opportunities for sensitive plasma proteome analysis (2012)
- Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test (2012)
- Differentiation of mast cell subpopulations from mouse embryonic stem cells (2012)
Alla publikationer
Artiklar
- Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens (2016)
- Öppenheten förstör chansen till patent (2015)
- Opportunities for sensitive plasma proteome analysis (2012)
- Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test (2012)
- Differentiation of mast cell subpopulations from mouse embryonic stem cells (2012)
- Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos. (2011)
- Retention and maternal transfer of brominated dioxins in zebrafish (Danio rerio) and effects on reproduction, aryl hydrocarbon receptor-regulated genes, and ethoxyresorufin-O-deethylase (EROD) activity. (2011)
- Effects of cadmium on calcium transporter SPCA, calcium homeostasis and β-casein expression in the murine mammary epithelium. (2011)
- Biphasic hormonal responses to the adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE in human cells (2010)
- Mast cell survival and mediator secretion in response to hypoxia. (2010)
- Mixture effects of imidazole fungicides on cortisol and aldosterone secretion in human adrenocortical H295R cells. (2010)
- Mixture effects of dietary flavonoids on steroid hormone synthesis in the human adrenocortical H295R cell line. (2010)
- A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells--underlying mechanisms. (2009)
- NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells. (2008)
- Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption - screening of 30 selected chemicals in the human H295R cell model. (2008)
- Steroidogenic gene expression in H295R cells and the human adrenal gland (2006)
- Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). (2005)
- "Fluorescent Cell Chip" for immunotoxicity testing (2005)
- Development of the "Cell Chip" (2005)
- Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma (2003)
- Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer (2002)
- Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. (2001)
- The sequential activation and repression of the human PDGF-B gene during chronic hypoxia reveals antagonistic roles for the depletion of oxygen and glucose (2001)
- The 5' flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer-promoter communication (2000)
- A novel type of regulatory element is required for promoter-specific activity of the PDGF-B intronic enhancer region. (1998)
- Cell-type-specific modulation of PDGF-B regulatory elements via viral enhancer competition: A caveat for the use of reference plasmids in transient transfection assays (1996)
- An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer (1995)
